Pancreatic neuroendocrine tumor treatment in Germany may include surgery, organ-preserving approaches and active surveillance for localized tumors. Advanced disease may require hormone control, systemic medicines, chemotherapy or PRRT, while selected...
Lutetium-177-DOTATATE is a receptor-directed radioligand treatment used for advanced, somatostatin-receptor-positive pancreatic neuroendocrine tumors. This guide explains who may be suitable for PRRT, how receptor imaging supports treatment decisions...
Pancreatic cancer survival statistics describe groups rather than individuals. This article explains five-year survival rates and how they differ by stage, the difference between median survival, average survival and life expectancy, and the disease,...
TACE for pancreatic cancer is a selective, liver-directed treatment used in selected patients with liver metastases. The procedure delivers chemotherapy to vessels supplying the target tumour and uses embolization to reduce blood flow. The article co...
Immunotherapy may offer a treatment option for selected patients with pancreatic cancer, particularly those with MSI-H, dMMR or TMB-H biomarkers. Treatment approaches discussed include pembrolizumab, other checkpoint inhibitors, cancer vaccines, CAR-...
Targeted therapy for pancreatic cancer focuses on molecular changes that may help doctors match a tumour with a specific treatment. The article explains molecular and genetic testing, who may be eligible for treatments such as PARP inhibitors, other...
Pancreatic cancer chemotherapy may be used before or after surgery or when the cancer cannot be removed. Treatment can include FOLFIRINOX, gemcitabine-based regimens, and NALIRIFOX, depending on the disease and the patient’s overall condition. It als...
Radiation therapy may play a role in the treatment of pancreatic cancer by helping control local disease or relieve symptoms in selected patients. Treatment depends on the cancer stage, tumour location, response to systemic therapy, and overall treat...
The Whipple procedure is a major operation used for selected pancreatic tumours, with suitability depending on resectability, tumour characteristics, and the patient’s overall condition. This article covers surgical approaches, preparation, resection...
Breast cancer screening and diagnostic tests help doctors detect and evaluate breast abnormalities at different stages. This guide covers the main imaging methods, including mammography, ultrasound, and MRI, as well as biopsy and receptor testing use...
Breast cancer symptoms can range from a distinct lump to subtle skin or nipple changes, and some early cases cause no symptoms at all. This article explains the warning signs to watch for, how symptoms differ in men and in specific subtypes such as i...
Surgical treatment for pancreatic cancer depends on the tumour’s location and extent, its relationship with nearby blood vessels, and the patient’s overall health. This article explains how these factors influence surgical options and eligibility, wh...
Pancreatic cancer diagnosis usually involves several tests, with each providing different information. This article explains how blood tests, CA 19-9, CT, abdominal ultrasound, MRI with MRCP, endoscopic ultrasound, and biopsy are used to investigate...
Pancreatic cancer includes several tumour types that differ in their cells of origin, biological characteristics, and clinical behaviour. The main types include pancreatic ductal adenocarcinoma (PDAC), neuroendocrine tumours, rare exocrine cancers, a...
Breast cancer treatment now depends heavily on tumour biology, and immunotherapy has become a key option for certain subtypes. This article explains how breast cancer is diagnosed and staged in Germany, the standard treatment options, and how immunot...